{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:58:18Z","timestamp":1782453498419,"version":"3.54.5"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.vph.2025.107517","type":"journal-article","created":{"date-parts":[[2025,6,22]],"date-time":"2025-06-22T17:39:22Z","timestamp":1750613962000},"page":"107517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Explosive discovery, surprising future: The extraordinary journey of nitroglycerin, nitroderivatives and nitric oxide"],"prefix":"10.1016","volume":"160","author":[{"given":"Maria Rosa","family":"Montinari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Minelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Horowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaele","family":"De Caterina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2025.107517_bb0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.amjms.2018.04.011","article-title":"The beat goes on: the story of five ageless cardiac drugs","volume":"356","author":"Smulyan","year":"2018","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.vph.2025.107517_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2018.10.008","article-title":"The first 3500 years of aspirin history from its roots\u2013a concise summary","volume":"113","author":"Montinari","year":"2019","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2025.107517_bb0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2021.106918","article-title":"Eighty years of oral anticoagulation: learning from history","volume":"141","author":"Montinari","year":"2021","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2025.107517_bb0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1440-1681.2000.03240.x","article-title":"A short history of nitroglycerine and nitric oxide in pharmacology and physiology","volume":"27","author":"Marsh","year":"2000","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.vph.2025.107517_bb0025","first-page":"59","article-title":"Some account of a disorder of the heart","volume":"2","author":"Heberden","year":"1772","journal-title":"Med. Trans. R. Coll. Phys."},{"key":"10.1016\/j.vph.2025.107517_bb0030","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/eurheartj\/ehac643","article-title":"Reprising Heberden\u2019s description of angina pectoris after 250 years","volume":"44","author":"Boden","year":"2023","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2025.107517_bb0035","first-page":"L111","article-title":"Joseph Priestley, oxygen, and the enlightenment","volume":"306","author":"West","year":"2014","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.vph.2025.107517_bb0040","series-title":"Experiments and Observations on Different Kinds of Air","author":"Priestley","year":"1776"},{"key":"10.1016\/j.vph.2025.107517_bb0045","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1068\/p3305ed","article-title":"Joseph Priestley (1733-1804)","volume":"33","author":"Wade","year":"2004","journal-title":"Perception"},{"key":"10.1016\/j.vph.2025.107517_bb0050","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1056\/NEJMsr1503311","article-title":"Nitroglycerin and nitric oxide\u2013a Rondo of themes in cardiovascular therapeutics","volume":"373","author":"Steinhorn","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2025.107517_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00003495-198700334-00003","article-title":"Historical aspects of nitrate therapy","volume":"33","author":"Berlin","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.vph.2025.107517_bb0060","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3406\/pharm.2015.22907","article-title":"Theophile-Jules Pelouze (1807-1867) was one of the French pharmacists who has the most contributed to the evolution of the organic chemisty in the first half of the 19th century","volume":"62","author":"Arnaud","year":"2015","journal-title":"Rev. Hist. Pharm. (Paris)"},{"key":"10.1016\/j.vph.2025.107517_bb0065","doi-asserted-by":"crossref","first-page":"6581","DOI":"10.3390\/molecules26216581","article-title":"Glyceryl trinitrate: history, mystery, and alcohol intolerance","volume":"26","author":"Pearson","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.vph.2025.107517_bb0070","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2459\/JCM.0b013e3283621ac6","article-title":"Nitroglycerine and sodium trioxodinitrate: from the discovery to the preconditioning effect","volume":"14","author":"Pagliaro","year":"2013","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"key":"10.1016\/j.vph.2025.107517_bb0075","first-page":"491","article-title":"Development of glonoin","volume":"5","author":"Munch","year":"1965","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.vph.2025.107517_bb0080","series-title":"Sur plusieurs compos\u00e9s d\u00e9tonants produits avec l\u2019acide nitrique et le sucre, la dextrine, la lactine, la mannite et la glycerine (Extrait d\u2019une lettre a M.Pelouze). Comptes Rendus","first-page":"247","volume":"24","author":"Sobrero","year":"1847"},{"key":"10.1016\/j.vph.2025.107517_bb0085","series-title":"A Cyclopaedia of Drug Pathogenesy","author":"Hughes","year":"1888"},{"key":"10.1016\/j.vph.2025.107517_bb0090","first-page":"8","article-title":"Alfred Nobel and his prizes: from dynamite to DNA","author":"Lichtman","year":"2017","journal-title":"Rambam Maimonides Med. J."},{"key":"10.1016\/j.vph.2025.107517_bb0095","series-title":"Alfred Nobel: A Biography","author":"Fant","year":"2007"},{"key":"10.1016\/j.vph.2025.107517_bb0100","author":"Sobrero"},{"key":"10.1016\/j.vph.2025.107517_bb0105","series-title":"The Legacy of Alfred Nobel: The Story Behind the Nobel Prizes","author":"Sohlman","year":"1983"},{"key":"10.1016\/j.vph.2025.107517_bb0110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3406\/pharm.2003.5517","article-title":"Antoine J\u00e9r\u00f4me Balard. The man","volume":"51","author":"Charlot","year":"2003","journal-title":"Rev. Hist. Pharm. (Paris)"},{"key":"10.1016\/j.vph.2025.107517_bb0115","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1039\/QJ8591100245","article-title":"XX.\u2014contributions to the knowledge of the amyl group","volume":"11","author":"Guthrie","year":"1859","journal-title":"Quart. J. Chem. Soc. Lond."},{"key":"10.1016\/j.vph.2025.107517_bb0120","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/01.CIR.74.2.222","article-title":"Lauder Brunton and amyl nitrite: a Victorian vasodilator","volume":"74","author":"Fye","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107517_bb0125","first-page":"120","article-title":"Report on the physiological action of nitrite of amyl","volume":"34","author":"Richardson","year":"1864","journal-title":"Rep. Br. Assoc. Adv. Sci."},{"key":"10.1016\/j.vph.2025.107517_bb0130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0140-6736(02)51392-1","article-title":"On the use of nitrite of amyl in angina pectoris","volume":"90","author":"Brunton","year":"1867","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2025.107517_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112878","article-title":"From ancient leech to direct thrombin inhibitors and beyond: new from old","volume":"149","author":"Montinari","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.vph.2025.107517_bb0140","first-page":"92","article-title":"The action of nitrate of amyl on the circulation","volume":"5","author":"Brunton","year":"1870","journal-title":"J. Anat. Physiol."},{"key":"10.1016\/j.vph.2025.107517_bb0145","series-title":"EJ Marey and Cardiology: Physiologist and Pioneer of Technology, 1830\u20131904: Selected Writings in Facsimile with Comments and Summaries, a Brief History of Life and Work, and a Bibliography","author":"Snellen","year":"1980"},{"key":"10.1016\/j.vph.2025.107517_bb0150","series-title":"Pharmacology and Therapeutics: Or, Medicine Past and Present","author":"Brunton","year":"1880"},{"key":"10.1016\/j.vph.2025.107517_bb0155","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/00000441-187107000-00002","article-title":"Experimental researches on the physiological action of nitrite of amyl","volume":"62","author":"Wood","year":"1871","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.vph.2025.107517_bb0160","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00000441-187110000-00003","article-title":"On the therapeutic value of nitrite of amyl","volume":"62","author":"Wood","year":"1871","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.vph.2025.107517_bb0165","first-page":"1448","article-title":"Effect vasodilatateur du nitrite d\u2019amyle sur les vaisseaux de l\u2019corce crebrale et sur les vaisseaux du myocarde","volume":"55","author":"Francois-Frank","year":"1903","journal-title":"C. R. Soc. Biol."},{"key":"10.1016\/j.vph.2025.107517_bb0170","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1001\/jama.1969.03160220051017","article-title":"William Murrell (1853-1912) clinical pharmacologist and toxicologist","volume":"209","year":"1969","journal-title":"JAMA"},{"key":"10.1016\/j.vph.2025.107517_bb0175","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/S0140-6736(02)46032-1","article-title":"Nitro-glycerine as a remedy for angina pectoris","volume":"1","author":"Murrell","year":"1879","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2025.107517_bb0180","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/01.CIR.73.1.21","article-title":"Nitroglycerin: a homeopathic remedy","volume":"73","author":"Fye","year":"1986","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107517_bb0185","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1056\/NEJM188112221052515","volume":"105","year":"1881","journal-title":"Boston Med. Surg. J."},{"key":"10.1016\/j.vph.2025.107517_bb0190","series-title":"Nitrite and Nitrate in Human Health and Disease","first-page":"195","article-title":"Pharmacology of nitrovasodilators","author":"M\u00fcnzel","year":"2017"},{"key":"10.1016\/j.vph.2025.107517_bb0195","series-title":"Goodman & Gilman\u2019s the Pharmacological Basis of Therapeutics","author":"Brunton","year":"2023"},{"key":"10.1016\/j.vph.2025.107517_bb0200","doi-asserted-by":"crossref","first-page":"30b","DOI":"10.1016\/0002-9149(92)90592-M","article-title":"Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia","volume":"70","author":"Abrams","year":"1992","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.vph.2025.107517_bb0205","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/01.RES.22.5.649","article-title":"Effect of nitroglycerin and dipyridamole on regional coronary resistance","volume":"22","author":"Fam","year":"1968","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2025.107517_bb0210","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1056\/NEJM199802193380807","article-title":"Nitrate therapy for stable angina pectoris","volume":"338","author":"Parker","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2025.107517_bb0215","doi-asserted-by":"crossref","first-page":"41c","DOI":"10.1016\/S0002-9149(96)00188-9","article-title":"Nitrates in the treatment of congestive heart failure","volume":"77","author":"Elkayam","year":"1996","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.vph.2025.107517_bb0220","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1755-5922.2012.00311.x","article-title":"When should we use nitrates in congestive heart failure?","volume":"31","author":"Vizzardi","year":"2013","journal-title":"Cardiovasc. Ther."},{"issue":"Suppl. 1","key":"10.1016\/j.vph.2025.107517_bb0225","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000176443","article-title":"Nitro derivatives as antiplatelet agents","volume":"84","author":"De Caterina","year":"1994","journal-title":"Cardiology"},{"key":"10.1016\/j.vph.2025.107517_bb0230","first-page":"255","article-title":"Glonoin or nitro glycerine [Americanische Arzneipr\u00fcfungen, translated with additions. History as proved and applied by C. Hering, Philadelphia, 1847-1851]","volume":"9","author":"Hering","year":"1874","journal-title":"N. Engl. Med. Gaz."},{"key":"10.1016\/j.vph.2025.107517_bb0235","first-page":"291","article-title":"On the toxical and medicinal properties of nitrate of oxyde of glycyl","volume":"16","author":"Field","year":"1858","journal-title":"Med. Times Gaz."},{"key":"10.1016\/j.vph.2025.107517_bb0240","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1093\/jhmas\/45.3.317","article-title":"Vasodilator therapy for angina pectoris: the intersection of homeopathy and scientific medicine","volume":"45","author":"Fye","year":"1990","journal-title":"J. Hist. Med. Allied Sci."},{"key":"10.1016\/j.vph.2025.107517_bb0245","series-title":"A Text-Book of Pharmacology, Therapeutics and Materia Medica","author":"Brunton","year":"1885"},{"key":"10.1016\/j.vph.2025.107517_bb0250","first-page":"37","article-title":"Nitroglycerin in pharmacy","volume":"24","author":"Martindale","year":"1880","journal-title":"Practitioner"},{"key":"10.1016\/j.vph.2025.107517_bb0255","series-title":"Nitro-Glycerine as a Remedy for Angina Pectoris","author":"Murrell","year":"1882"},{"key":"10.1016\/j.vph.2025.107517_bb0260","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S0140-6736(02)28212-4","article-title":"Nitro-glycerine tablets","volume":"126","author":"Murrell","year":"1885","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2025.107517_bb0265","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1093\/eurheartj\/eht249","article-title":"More answers to the still unresolved question of nitrate tolerance","volume":"34","author":"M\u00fcnzel","year":"2013","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2025.107517_bb0270","series-title":"Cardiac Drug Therapy","author":"Khan","year":"2007"},{"key":"10.1016\/j.vph.2025.107517_bb0275","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/CRD.0b013e3181c8e14a","article-title":"Nitrates and nitrites in the treatment of ischemic cardiac disease","volume":"18","author":"Nossaman","year":"2010","journal-title":"Cardiol. Rev."},{"key":"10.1016\/j.vph.2025.107517_bb0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vph.2017.11.003","article-title":"Inorganic nitrite and nitrate in cardiovascular therapy: a better alternative to organic nitrates as nitric oxide donors?","volume":"102","author":"M\u00fcnzel","year":"2018","journal-title":"Vasc. Pharmacol."},{"key":"10.1016\/j.vph.2025.107517_bb0285","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1161\/CIRCULATIONAHA.110.981407","article-title":"Nitrate therapy: new aspects concerning molecular action and tolerance","volume":"123","author":"M\u00fcnzel","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107517_bb0290","series-title":"The ESC Handbook on Cardiovascular Pharmacotherapy","author":"Kaski","year":"2019"},{"key":"10.1016\/j.vph.2025.107517_bb0295","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM194610102351503","article-title":"The cause, relief and prevention of headaches arising from contact with dynamite","volume":"235","author":"Schwartz","year":"1946","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2025.107517_bb0300","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1161\/01.CIR.0000036743.07406.53","article-title":"Nitrate tolerance: a unifying hypothesis","volume":"106","author":"Gori","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107517_bb0305","first-page":"43","article-title":"Remarkable tolerance to nitroglycerin","volume":"6","author":"Stewart","year":"1888","journal-title":"Philadelphia Polyclin."},{"key":"10.1016\/j.vph.2025.107517_bb0310","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1089\/ars.2015.6376","article-title":"Organic nitrate therapy, nitrate tolerance, and nitrate-induced endothelial dysfunction: emphasis on redox biology and oxidative stress","volume":"23","author":"Daiber","year":"2015","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.vph.2025.107517_bb0315","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1161\/01.CIR.102.23.2810","article-title":"Nitroglycerin tolerance in human vessels: evidence for impaired nitroglycerin bioconversion","volume":"102","author":"Sage","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107517_bb0320","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1476-5381.1989.tb14603.x","article-title":"S-nitrosothiols as vasodilators: implications regarding tolerance to nitric oxide-containing vasodilators","volume":"98","author":"Henry","year":"1989","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2025.107517_bb0325","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/0002-9149(91)90252-G","article-title":"The mystery of nitrate resistance","volume":"68","author":"Abrams","year":"1991","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.vph.2025.107517_bb0330","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1161\/01.CIR.100.2.129","article-title":"Nitrate resistance in platelets from patients with stable angina pectoris","volume":"100","author":"Chirkov","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107517_bb0335","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.jacc.2006.08.053","article-title":"The deleterious effects of hyperglycemia on platelet function in diabetic patients with acute coronary syndromes mediation by superoxide production, resolution with intensive insulin administration","volume":"49","author":"Worthley","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2025.107517_bb0340","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.pharmthera.2007.06.012","article-title":"Impaired tissue responsiveness to organic nitrates and nitric oxide: a new therapeutic frontier?","volume":"116","author":"Chirkov","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.vph.2025.107517_bb0345","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1161\/01.ATV.0000193622.77294.57","article-title":"Platelet nitric oxide responsiveness: a novel prognostic marker in acute coronary syndromes","volume":"25","author":"Willoughby","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.vph.2025.107517_bb0350","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jacc.2012.01.066","article-title":"Ramipril sensitizes platelets to nitric oxide: implications for therapy in high-risk patients","volume":"60","author":"Willoughby","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2025.107517_bb0355","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1056\/NEJM198706043162303","article-title":"Effect of intervals between doses on the development of tolerance to isosorbide dinitrate","volume":"316","author":"Parker","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2025.107517_bb0360","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0167-5273(94)90262-3","article-title":"Risk of rebound phenomenon during nitrate withdrawal","volume":"45","author":"Ferratini","year":"1994","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.vph.2025.107517_bb0365","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1161\/CIRCULATIONAHA.117.027575","volume":"136","author":"Pasupathy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107517_bb0370","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0140-6736(97)08417-1","article-title":"Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema","volume":"351","author":"Cotter","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2025.107517_bb0375","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1071-9164(98)90232-9","article-title":"Nitrate therapy is an alternative to furosemide\/morphine therapy in the management of acute cardiogenic pulmonary edema","volume":"4","author":"Beltrame","year":"1998","journal-title":"J. Card. Fail."},{"key":"10.1016\/j.vph.2025.107517_bb0380","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1056\/NEJMoa042934","article-title":"Combination of isosorbide dinitrate and hydralazine in blacks with heart failure","volume":"351","author":"Taylor","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2025.107517_bb0385","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1056\/NEJMsa063904","article-title":"Nitric oxide and cyclic GMP in cell signaling and drug development","volume":"355","author":"Murad","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2025.107517_bb0390","first-page":"23","article-title":"Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations and comparison to the effects of sodium azide and hydroxylamine","volume":"3","author":"Katsuki","year":"1977","journal-title":"J. Cyclic Nucleotide Res."},{"key":"10.1016\/j.vph.2025.107517_bb0395","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0026-895X(25)11207-8","article-title":"Regulation of adenosine cyclic 3\u2032,5\u2032-monophosphate and guanosine cyclic 3\u2032,5\u2032-monophosphate levels and contractility in bovine tracheal smooth muscle","volume":"13","author":"Katsuki","year":"1977","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.vph.2025.107517_bb0400","doi-asserted-by":"crossref","first-page":"3203","DOI":"10.1073\/pnas.74.8.3203","article-title":"Nitric oxide activates guanylate cyclase and increases guanosine 3\u2032: 5\u2032-cyclic monophosphate levels in various tissue preparations","volume":"74","author":"Arnold","year":"1977","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.vph.2025.107517_bb0405","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2741\/3228","article-title":"Discovery of the nitric oxide signaling pathway and targets for drug development","volume":"14","author":"Bryan","year":"2009","journal-title":"Front. Biosci. (Landmark Ed)"},{"key":"10.1016\/j.vph.2025.107517_bb0410","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s10540-005-2741-8","article-title":"Discovery of some of the biological effects of nitric oxide and its role in cell signaling","volume":"24","author":"Murad","year":"2004","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.vph.2025.107517_bb0415","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1111\/j.1751-7176.2008.06632.x","article-title":"Vascular system: role of nitric oxide in cardiovascular diseases","volume":"10","author":"Bian","year":"2008","journal-title":"J. Clin. Hypertens. (Greenwich)"},{"key":"10.1016\/j.vph.2025.107517_bb0420","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/288373a0","article-title":"The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine","volume":"288","author":"Furchgott","year":"1980","journal-title":"Nature"},{"key":"10.1016\/j.vph.2025.107517_bb0425","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1073\/pnas.79.6.2106","article-title":"Role of endothelial cells in relaxation of isolated arteries by bradykinin","volume":"79","author":"Cherry","year":"1982","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.vph.2025.107517_bb0430","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1093\/eurheartj\/ehu427","article-title":"2014 Williams Harvey lecture: importance of coronary vasomotion abnormalities\u2014from bench to bedside","volume":"35","author":"Shimokawa","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2025.107517_bb0435","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/327524a0","article-title":"Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor","volume":"327","author":"Palmer","year":"1987","journal-title":"Nature"},{"key":"10.1016\/j.vph.2025.107517_bb0440","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1161\/01.RES.61.6.866","article-title":"Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical","volume":"61","author":"Ignarro","year":"1987","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2025.107517_bb0445","doi-asserted-by":"crossref","first-page":"9265","DOI":"10.1073\/pnas.84.24.9265","article-title":"Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide","volume":"84","author":"Ignarro","year":"1987","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.vph.2025.107517_bb0450","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.RES.65.1.1","article-title":"Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein","volume":"65","author":"Ignarro","year":"1989","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2025.107517_bb0455","first-page":"13","article-title":"Controversies in selecting Nobel laureates: an historical commentary","author":"Lichtman","year":"2022","journal-title":"Rambam Maimonides Med. J."},{"key":"10.1016\/j.vph.2025.107517_bb0460","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/25215","article-title":"Protest at Nobel omission of Moncada","volume":"396","author":"Guill\u00e9n","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.vph.2025.107517_bb0465","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/eurheartj\/ehl452","article-title":"The making of a physician-scientist\u2013the process has a pattern: lessons from the lives of Nobel laureates in medicine and physiology","volume":"28","author":"Archer","year":"2007","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2025.107517_bb0470","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/263663a0","article-title":"An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation","volume":"263","author":"Moncada","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.vph.2025.107517_bb0475","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1126\/science.1281928","article-title":"Biochemistry of nitric oxide and its redox-activated forms","volume":"258","author":"Stamler","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.vph.2025.107517_bb0480","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.bi.63.070194.001135","article-title":"Nitric oxide: a physiologic messenger molecule","volume":"63","author":"Bredt","year":"1994","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.vph.2025.107517_bb0485","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0891-5849(98)00092-6","article-title":"Chemical biology of nitric oxide: insights into regulatory, cytotoxic, and cytoprotective mechanisms of nitric oxide","volume":"25","author":"Wink","year":"1998","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.vph.2025.107517_bb0490","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/014107689909200402","article-title":"Nitric oxide: discovery and impact on clinical medicine","volume":"92","author":"Moncada","year":"1999","journal-title":"J. R. Soc. Med."},{"key":"10.1016\/j.vph.2025.107517_bb0495","series-title":"Nitric Oxide: Biology and Pathobiology","author":"Ignarro","year":"2000"},{"key":"10.1016\/j.vph.2025.107517_bb0500","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1042\/bj3570593","article-title":"Nitric oxide synthases: structure, function and inhibition","volume":"357","author":"Alderton","year":"2001","journal-title":"Biochem. J."},{"key":"10.1016\/j.vph.2025.107517_bb0505","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2025.107517_bb0510","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.1073\/pnas.89.14.6348","article-title":"Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform","volume":"89","author":"Lamas","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.vph.2025.107517_bb0515","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0014-5793(92)80697-F","article-title":"Molecular cloning and characterization of human endothelial nitric oxide synthase","volume":"307","author":"Marsden","year":"1992","journal-title":"FEBS Lett."},{"key":"10.1016\/j.vph.2025.107517_bb0520","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S1054-3589(08)60054-X","article-title":"Effects of cyclic GMP on smooth muscle relaxation","volume":"26","author":"Warner","year":"1994","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.vph.2025.107517_bb0525","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1172\/JCI118074","article-title":"Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines","volume":"96","author":"De Caterina","year":"1995","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.vph.2025.107517_bb0530","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2741\/997","article-title":"Nitric oxide (NO)-biogeneration, regulation, and relevance to human diseases","volume":"8","author":"Bian","year":"2003","journal-title":"Front. Biosci."},{"key":"10.1016\/j.vph.2025.107517_bb0535","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.atherosclerosis.2014.09.001","article-title":"Vascular oxidative stress, nitric oxide and atherosclerosis","volume":"237","author":"Li","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.vph.2025.107517_bb0540","article-title":"Nitric oxide: physiological functions, delivery, and biomedical applications","volume":"10","author":"Andrabi","year":"2023","journal-title":"Adv. Sci. (Weinh)"},{"key":"10.1016\/j.vph.2025.107517_bb0545","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/01.RES.0000088351.58510.21","article-title":"Nitric oxide and cardiac function: ten years after, and continuing","volume":"93","author":"Massion","year":"2003","journal-title":"Circ. Res."},{"key":"10.1016\/j.vph.2025.107517_bb0550","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ajpath.2023.09.012","article-title":"The role of endothelial cells in atherosclerosis: insights from genetic association studies","volume":"194","author":"Pepin","year":"2024","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.vph.2025.107517_bb0555","doi-asserted-by":"crossref","first-page":"8306","DOI":"10.1073\/pnas.122225199","article-title":"Identification of the enzymatic mechanism of nitroglycerin bioactivation","volume":"99","author":"Chen","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.vph.2025.107517_bb0560","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.tcm.2006.05.001","article-title":"Bioactivation of nitroglycerin by the mitochondrial aldehyde dehydrogenase","volume":"16","author":"Chen","year":"2006","journal-title":"Trends Cardiovasc. Med."},{"key":"10.1016\/j.vph.2025.107517_bb0565","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1111\/bph.13122","article-title":"Role of aldehyde dehydrogenase in hypoxic vasodilator effects of nitrite in rats and humans","volume":"172","author":"Arif","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2025.107517_bb0570","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/14728222.2018.1439922","article-title":"The potential of aldehyde dehydrogenase 2 as a therapeutic target in cardiovascular disease","volume":"22","author":"M\u00fcnzel","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.vph.2025.107517_bb0575","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1126\/science.1361684","article-title":"NO news is good news","volume":"258","author":"Culotta","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.vph.2025.107517_bb0580","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1161\/01.CIR.98.22.2365","article-title":"Nobel prize awarded to scientists for nitric oxide discoveries","volume":"98","author":"SoRelle","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107517_bb0585","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S0300-8932(99)74902-X","article-title":"The Nobel prize for nitric oxide. The unjust exclusion of Dr. Salvador Moncada","volume":"52","author":"de Berrazueta","year":"1999","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.vph.2025.107517_bb0590","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0006-291X(90)92168-Y","article-title":"Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle","volume":"170","author":"Ignarro","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.vph.2025.107517_bb0595","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1056\/NEJM199201093260203","article-title":"Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission","volume":"326","author":"Rajfer","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2025.107517_bb0600","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/0960-894X(96)00323-X","article-title":"Sildenafil (VIAGRATM), a potent and selective inhibitor of type 5 cGMP phosphodiesterase with utility for the treatment of male erectile dysfunction","volume":"6","author":"Terrett","year":"1996","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.vph.2025.107517_bb0605","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1056\/NEJMoa050010","article-title":"Sildenafil citrate therapy for pulmonary arterial hypertension","volume":"353","author":"Gali\u00e8","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2025.107517_bb0610","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.123.068107","article-title":"Randomized, multicenter study to assess the effects of different doses of sildenafil on mortality in adults with pulmonary arterial hypertension","author":"Hoeper","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107517_bb0615","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jacc.2023.10.045","article-title":"Randomized trial of Macitentan\/Tadalafil single-tablet combination therapy for pulmonary arterial hypertension","volume":"83","author":"Gr\u00fcnig","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.vph.2025.107517_bb0620","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.juro.2008.06.079","article-title":"Tadalafil administered once daily for lower urinary tract symptoms secondary to benign prostatic hyperplasia: a dose finding study","volume":"180","author":"Roehrborn","year":"2008","journal-title":"J. Urol."},{"key":"10.1016\/j.vph.2025.107517_bb0625","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1056\/NEJMoa1209655","article-title":"Riociguat for the treatment of pulmonary arterial hypertension","volume":"369","author":"Ghofrani","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2025.107517_bb0630","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa1915928","article-title":"Vericiguat in patients with heart failure and reduced ejection fraction","volume":"382","author":"Armstrong","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.vph.2025.107517_bb0635","first-page":"22","article-title":"The roles of nitric oxide synthase\/nitric oxide pathway in the pathology of vascular dementia and related therapeutic approaches","author":"Zhu","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vph.2025.107517_bb0640","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/bph.14532","article-title":"NO as a multimodal transmitter in the brain: discovery and current status","volume":"176","author":"Garthwaite","year":"2019","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.vph.2025.107517_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216931","article-title":"Unveiling the significance of inducible nitric oxide synthase: its impact on cancer progression and clinical implications","volume":"592","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.vph.2025.107517_bb0650","first-page":"21","article-title":"The role of nitric oxide in cancer: master regulator or not?","author":"Khan","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vph.2025.107517_bb0655","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1093\/eurheartj\/ehae100","article-title":"Inorganic nitrate benefits contrast-induced nephropathy after coronary angiography for acute coronary syndromes: the NITRATE-CIN trial","volume":"45","author":"Jones","year":"2024","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.vph.2025.107517_bb0660","doi-asserted-by":"crossref","DOI":"10.1161\/circ.146.suppl_1.10765","article-title":"Association between prehospital nitroglycerin and clinical outcome in acute coronary syndrome","volume":"146","author":"Komaki","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2025.107517_bb0665","first-page":"11","article-title":"Nitroglycerin use and adverse clinical outcomes in elderly patients with acute coronary syndrome","author":"Komaki","year":"2024","journal-title":"Open Heart"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189125000564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189125000564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T13:15:14Z","timestamp":1763644514000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189125000564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":133,"alternative-id":["S1537189125000564"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2025.107517","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Explosive discovery, surprising future: The extraordinary journey of nitroglycerin, nitroderivatives and nitric oxide","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2025.107517","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107517"}}